|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 712.77 USD | -0.30% |
|
+0.50% | -7.66% |
| Capitalization | 7.25TCr 6.15TCr 5.64TCr 5.31TCr 9.91TCr 6,90900Cr 9.99TCr 67TCr 26TCr 3,29000Cr 27TCr 27TCr 11,38700Cr | P/E ratio 2026 * |
18.5x | P/E ratio 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise value | 6.56TCr 5.57TCr 5.1TCr 4.81TCr 8.97TCr 6,25500Cr 9.04TCr 61TCr 24TCr 2,97900Cr 25TCr 24TCr 10,30800Cr | EV / Sales 2026 * |
4.13x | EV / Sales 2027 * | 3.48x |
| Free-Float |
72.33% | Yield 2026 * |
0.55% | Yield 2027 * | 0.62% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.30% | ||
| 1 week | +0.50% | ||
| Current month | +0.81% | ||
| 1 month | -4.82% | ||
| 3 months | -8.50% | ||
| 6 months | +5.67% | ||
| Current year | -7.66% |
| 1 week | 701.99 | 727.38 | |
| 1 month | 668.84 | 767.21 | |
| Current year | 668.84 | 821.11 | |
| 1 year | 476.49 | 821.11 | |
| 3 years | 476.49 | 1,211.2 | |
| 5 years | 476.49 | 1,211.2 | |
| 10 years | 271.37 | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.30% | +0.50% | +35.05% | -4.40% | 7.25TCr | ||
| +1.27% | +3.29% | +50.68% | +179.92% | 5.29TCr | ||
| -0.95% | +45.80% | +45.80% | +45.80% | 4.59TCr | ||
| -2.18% | -20.79% | -58.09% | -67.83% | 3.55TCr | ||
| +2.33% | +5.74% | +67.51% | -36.26% | 2.92TCr | ||
| -2.70% | +11.80% | +118.06% | -58.82% | 2.1TCr | ||
| +0.51% | -3.59% | +79.55% | +123.14% | 1.96TCr | ||
| +1.79% | +3.27% | +70.09% | +56.33% | 2TCr | ||
| -0.72% | +1.38% | +44.93% | +86.60% | 1.67TCr | ||
| -4.02% | -6.25% | +89.29% | +353.58% | 1.27TCr | ||
| Average | -0.38% | -0.43% | +54.29% | +67.81% | 3.26TCr | |
| Weighted average by Cap. | -0.18% | -0.59% | +44.65% | +49.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.59TCr 1.35TCr 1.23TCr 1.16TCr 2.17TCr 1,51300Cr 2.19TCr 15TCr 5.71TCr 72TCr 5.96TCr 5.83TCr 2,49300Cr | 1.76TCr 1.49TCr 1.37TCr 1.29TCr 2.4TCr 1,67600Cr 2.42TCr 16TCr 6.33TCr 80TCr 6.6TCr 6.46TCr 2,76200Cr |
| Net income | 420.34Cr 356.7Cr 326.67Cr 308.01Cr 574.49Cr 40TCr 579.11Cr 3.87TCr 1.51TCr 19TCr 1.58TCr 1.54TCr 66TCr | 516.4Cr 438.22Cr 401.32Cr 378.4Cr 705.78Cr 49TCr 711.44Cr 4.76TCr 1.86TCr 23TCr 1.94TCr 1.9TCr 81TCr |
| Net Debt | -686.89Cr -582.89Cr -533.82Cr -503.32Cr -938.79Cr -65TCr -946.32Cr -6.33TCr -2.47TCr -31TCr -2.58TCr -2.52TCr -1,07900Cr | -1.13TCr -961.05Cr -880.15Cr -829.86Cr -1.55TCr -1,07900Cr -1.56TCr -10TCr -4.07TCr -51TCr -4.25TCr -4.16TCr -1,77800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 712.77 $ | -0.30% | 12,27,186 |
| 08/26/08 | 714.89 $ | +0.82% | 5,89,041 |
| 07/26/07 | 709.10 $ | -1.66% | 7,74,679 |
| 06/26/06 | 721.05 $ | +2.67% | 7,39,914 |
| 05/26/05 | 702.27 $ | -0.98% | 6,42,799 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















